SCHEMBL3189493

SCHEMBL3189493

O=C(Nc1cccc(Cl)c1)NC1CCC(OCc2c(F)cccc2F)CC1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 9/20 0.72
▸ MEN1 O00255 4/20 0.59
▸ KMT2A Q03164 4/20 0.59
▸ RAB9A P51151 4/20 0.59
▸ NPC1 O15118 3/20 0.59
▸ LMNA P02545 1/20 0.59
▸ EPHX1 P07099 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ ALDH1A1 P00352 3/20 0.54
▸ POLB P06746 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HTR1A P08908 1/20 0.46
▸ HTR7 P34969 1/20 0.46
▸ UBE2M P61081 1/20 0.46
▸ DCUN1D1 Q96GG9 1/20 0.46
▸ CXCR3 P49682 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3189486 1.00 EPHX2 (0.72) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3194087 0.89 EPHX2 (0.66) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3194077 0.89 EPHX2 (0.66) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3182153 0.89 EPHX2 (0.74) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3182145 0.89 EPHX2 (0.74) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3178477 0.88 EPHX2 (0.72) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3178470 0.88 EPHX2 (0.72) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3181050 0.87 EPHX2 (0.72) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3181043 0.87 EPHX2 (0.72) EPHX2MEN1KMT2ARAB9ANPC1
SCHEMBL3172705 0.87 EPHX2 (0.72) EPHX2MEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US claimed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-8476043-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-07-02 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 — — US disclosed
US-7662910-B2 Inhibitors for the soluble epoxide hydrolase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-02-16 — — US disclosed
US-20080188554-A1 METHODS OF TREATING AVIAN HYPERTENSION REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY TRANSFER (US) 2008-08-07 — — US disclosed
US-20080188554-A1 METHODS OF TREATING AVIAN HYPERTENSION REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY TRANSFER (US) 2008-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021448-A1 Inhibitors for the Soluble Epoxide Hydrolase EPHX1, EPHX2, NCEH1 EPHX2 2/4885MEN1 3635/4885KMT2A 2899/4885
US-20080188554-A1 METHODS OF TREATING AVIAN HYPERTENSION EPHX1, ERH, EPHX2 EPHX2 3/4885MEN1 3278/4885KMT2A 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback